Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Revenue (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Revenue for 2 consecutive years, with -$28000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Revenue changed N/A to -$28000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $292000.0, a 70.8% decrease, with the full-year FY2023 number at $10.0 million, changed N/A from a year prior.
  • Revenue was -$28000.0 for Q3 2025 at Mereo BioPharma, down from $500000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $9.0 million in Q2 2023 to a low of -$180000.0 in Q1 2025.